AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2023
Sep 29, 2023
35334_dirs_2023-09-29_f2b6ba79-8c54-4d4b-b957-fced46e6469e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2023-09-29
Reporting Person: Equels Thomas K (Director, CEO & President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-29 | Common Stock | P | 22676 | $0.441 | Acquired | 606836 | Direct |
More from AIM ImmunoTech Inc.
Share Issue/Capital Change
2026
Jun 11
Governance Information
2026
Jun 10
Capital/Financing Update
2026
Jun 10
Capital/Financing Update
2026
Jun 8
Report Publication Announcement
2026
Jun 4
Capital/Financing Update
2026
May 21
Capital/Financing Update
2026
May 21
Share Issue/Capital Change
2026
May 19
Capital/Financing Update
2026
May 19
Interim / Quarterly Report
2026
May 15